Skip to search formSkip to main contentSkip to account menu

COL4A2 gene

Known as: COLLAGEN, TYPE IV, ALPHA-2, collagen type IV alpha 2, COL4A2 
National Institutes of Health

Related topics

Related topics

1 relation
COL4A1 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Pathophysiological roles of canstatin on myofibroblasts after myocardial infarction in rats
2016
2016
Canstatin inhibits isoproterenol-induced apoptosis through preserving mitochondrial morphology in differentiated H9c2 cardiomyoblasts
Canstatin, a non-collagenous fragment, is cleaved from type IV collagen α2 chain, an essential component of basement membrane… 
2014
2014
Identification of a differential expression signature associated with tumorigenesis and metastasis of laryngeal carcinoma.
2012
2012
A Novel Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Promoter for Expressing Transgenes in the Halotolerant Alga Dunaliella salina
A major challenge for efficient transgene expression in Dunaliella salina is to find strong endogenous promoters to drive the… 
2008
2008
Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment
Given as a prophylactic treatment, a single muscle electrogene transfer of plasmid coding canstatin fused to human serum albumin… 
2007
2007
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer
Correction to: Cancer Gene Therapy (2007) 14, 251–261. doi: 10.1038/sj.cgt.7701005 The author name F Beermann was published… 
2007
2007
Functional expression of recombinant canstatin in stably transformed Drosophila melanogaster S2 cells.
Highly Cited
2006
Highly Cited
2006
Comparative integromics on Angiopoietin family members.
Angiopoietin-1 (ANGPT1), Angiopoietin-4 (ANGPT4), VEGF, FGF2, FGF4, HGF, Ephrin, IL8 and CXCL12 (SFD1) are pro-angiogenic factors… 
2004
2004
The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
2001
2001
Gene therapy for antiangiogenesis.
Angiogenesis inhibitors have evolved as a new diverse class of compounds that can be used to block tumor growth (1,2). The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)